These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29574065)

  • 1. Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study.
    Zignol M; Cabibbe AM; Dean AS; Glaziou P; Alikhanova N; Ama C; Andres S; Barbova A; Borbe-Reyes A; Chin DP; Cirillo DM; Colvin C; Dadu A; Dreyer A; Driesen M; Gilpin C; Hasan R; Hasan Z; Hoffner S; Hussain A; Ismail N; Kamal SMM; Khanzada FM; Kimerling M; Kohl TA; Mansjö M; Miotto P; Mukadi YD; Mvusi L; Niemann S; Omar SV; Rigouts L; Schito M; Sela I; Seyfaddinova M; Skenders G; Skrahina A; Tahseen S; Wells WA; Zhurilo A; Weyer K; Floyd K; Raviglione MC
    Lancet Infect Dis; 2018 Jun; 18(6):675-683. PubMed ID: 29574065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.
    Zignol M; Dean AS; Alikhanova N; Andres S; Cabibbe AM; Cirillo DM; Dadu A; Dreyer A; Driesen M; Gilpin C; Hasan R; Hasan Z; Hoffner S; Husain A; Hussain A; Ismail N; Kamal M; Mansjö M; Mvusi L; Niemann S; Omar SV; Qadeer E; Rigouts L; Ruesch-Gerdes S; Schito M; Seyfaddinova M; Skrahina A; Tahseen S; Wells WA; Mukadi YD; Kimerling M; Floyd K; Weyer K; Raviglione MC
    Lancet Infect Dis; 2016 Oct; 16(10):1185-1192. PubMed ID: 27397590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
    Xie YL; Chakravorty S; Armstrong DT; Hall SL; Via LE; Song T; Yuan X; Mo X; Zhu H; Xu P; Gao Q; Lee M; Lee J; Smith LE; Chen RY; Joh JS; Cho Y; Liu X; Ruan X; Liang L; Dharan N; Cho SN; Barry CE; Ellner JJ; Dorman SE; Alland D
    N Engl J Med; 2017 Sep; 377(11):1043-1054. PubMed ID: 28902596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Park J; Shin SY; Kim K; Park K; Shin S; Ihm C
    Ann Lab Med; 2018 Jul; 38(4):316-323. PubMed ID: 29611381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
    Al-Mutairi NM; Ahmad S; Mokaddas EM
    Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of
    Bablishvili N; Tukvadze N; Shashkina E; Mathema B; Gandhi NR; Blumberg HM; Kempker RR
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antituberculosis Drug Resistance in Pulmonary Isolates of Mycobacterium tuberculosis, Cuba 2012-2014.
    Lemus D; Echemendía M; Díaz R; Llanes MJ; Suárez L; Marrero A
    MEDICC Rev; 2017 Jan; 19(1):10-15. PubMed ID: 28225540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data.
    Dean AS; Zignol M; Cabibbe AM; Falzon D; Glaziou P; Cirillo DM; Köser CU; Gonzalez-Angulo LY; Tosas-Auget O; Ismail N; Tahseen S; Ama MCG; Skrahina A; Alikhanova N; Kamal SMM; Floyd K
    PLoS Med; 2020 Jan; 17(1):e1003008. PubMed ID: 31961877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A standardised method for interpreting the association between mutations and phenotypic drug resistance in
    Miotto P; Tessema B; Tagliani E; Chindelevitch L; Starks AM; Emerson C; Hanna D; Kim PS; Liwski R; Zignol M; Gilpin C; Niemann S; Denkinger CM; Fleming J; Warren RM; Crook D; Posey J; Gagneux S; Hoffner S; Rodrigues C; Comas I; Engelthaler DM; Murray M; Alland D; Rigouts L; Lange C; Dheda K; Hasan R; Ranganathan UDK; McNerney R; Ezewudo M; Cirillo DM; Schito M; Köser CU; Rodwell TC
    Eur Respir J; 2017 Dec; 50(6):. PubMed ID: 29284687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
    Campbell PJ; Morlock GP; Sikes RD; Dalton TL; Metchock B; Starks AM; Hooks DP; Cowan LS; Plikaytis BB; Posey JE
    Antimicrob Agents Chemother; 2011 May; 55(5):2032-41. PubMed ID: 21300839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of drug resistance-associated mutations among clinical multidrug-resistant Mycobacterium tuberculosis isolates from Hebei Province, China.
    Li Q; Wang Y; Li Y; Gao H; Zhang Z; Feng F; Dai E
    J Glob Antimicrob Resist; 2019 Sep; 18():168-176. PubMed ID: 30926465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
    Jnawali HN; Hwang SC; Park YK; Kim H; Lee YS; Chung GT; Choe KH; Ryoo S
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):187-96. PubMed ID: 23561273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hunan, China.
    Zhao LL; Chen Y; Chen ZN; Liu HC; Hu PL; Sun Q; Zhao XQ; Jiang Y; Li GL; Tan YH; Wan KL
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3475-80. PubMed ID: 24733464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrazinamide resistance and pncA mutations in drug resistant Mycobacterium tuberculosis clinical isolates from Myanmar.
    Ei PW; Mon AS; Htwe MM; Win SM; Aye KT; San LL; Zaw NN; Nyunt WW; Myint Z; Lee JS; Aung WW
    Tuberculosis (Edinb); 2020 Dec; 125():102013. PubMed ID: 33142220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid detection of isoniazid, rifampin, and ofloxacin resistance in Mycobacterium tuberculosis clinical isolates using high-resolution melting analysis.
    Chen X; Kong F; Wang Q; Li C; Zhang J; Gilbert GL
    J Clin Microbiol; 2011 Oct; 49(10):3450-7. PubMed ID: 21832014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis for detection of drug resistance in mycobacterium tuberculosis isolates from Khyber Pakhtunkhwa, Pakistan.
    Ahmad B; Idrees M; Ahmad K; Bashir S; Ahmad S; Lin-Fang H
    J Pak Med Assoc; 2017 Nov; 67(11):1684-1688. PubMed ID: 29171560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
    Dookie N; Sturm AW; Moodley P
    BMC Infect Dis; 2016 Oct; 16(1):609. PubMed ID: 27784282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa.
    Said HM; Kock MM; Ismail NA; Mphahlele M; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
    J Clin Microbiol; 2012 Sep; 50(9):2857-62. PubMed ID: 22649019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.